טוען...
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-related morbidity and mortality. Recent clinical evidences suggest increased level of cytokines and chemokines targeting lung tissue as a prominent etiological factor. The immunomodulatory effect of mesenchymal s...
שמור ב:
| הוצא לאור ב: | Hum Cell |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Singapore
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7418088/ https://ncbi.nlm.nih.gov/pubmed/32780299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13577-020-00407-w |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|